Controlled human malaria infection (CHMI) outcomes in Kenyan adults is associated with prior history of malaria exposure and anti-schizont antibody response by Kapulu, MC, Kimani, D, Njuguna, P, Hamaluba, M, Otieno, E, Kimathi, R, Tuju, J, Sim, BKL

protGear: A protein microarray data pre-processing suite by Mwai, K, Kibinge, N, Tuju, J, Kamuyu, G, Kimathi, R, Mburu, J, Chepsat, E, Nyamako, L, Chege, T, Nkumama, I, Kinyanjui, S, Musenge, E, Osier, F

Distinct kinetics of antibodies to 111 Plasmodium falciparum proteins identifies markers of recent malaria exposure by Yman, V, Tuju, J, White, MT, Kamuyu, G, Mwai, K, Kibinge, N, Asghar, M, Sundling, C, Sondén, K, Murungi, L, Kiboi, D, Kimathi, R, Chege, T, Chepsat, E, Kiyuka, P, Nyamako, L, Osier, FHA, Färnert, A

KILchip v1.0: a novel plasmodium falciparum merozoite protein microarray to facilitate malaria vaccine candidate prioritization by Kamuyu, G, Tuju, J, Kimathi, R, Mwai, K, Mburu, J, Kibinge, N, Kwan, M, Hawkings, S, Yaa, R, Chepsat, E, Njunge, J, Chege, T, Guleid, F, Rosenkranz, M, Kariuki, C, Frank, R, Kinyanjui, S, Murungi, L, Bejon, P, Farnert, A, Tetteh, K, Beeson, J, Conway, D, Marsh, K, Rayner, J, Osier, F